The pharmaceutical community is buzzing with anticipation surrounding retatrutide, a novel dual GIP and GLP-1 target that’s showing significant efficacy in clinical trials retatrutide jay campbell for managing obesity. Unlike some current weight loss solutions, retatrutide appears to deliver a greater substantial decrease in body size and enhance